SectorPharmaceutical
Established Date05/02/2018
Listing Date16/10/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees82
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressOne Corporate Drive, 2nd Floor, South San Francisco, California 94080
Business
IntroductionAligos Therapeutics, Inc., was incorporated in Delaware on February 5, 2018. The company is a clinical-stage biopharmaceutical company focused on developing novel therapies to address unmet medical needs in liver disease and viral infections.
